JF
KYTX icon

Jump Financial’s Kyverna Therapeutics KYTX Stock Holding History

Jump Financial’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$455K Sell
52,762
-27,537
-34% -$229K 0.01% 1298
2025
Q4 		$755K Buy
+80,299
New +$596K 0.01% 1103
2024
Q3 		– Sell
-66,960
Closed -$502K – 2194
2024
Q2 		$502K Buy
+66,960
New +$1.02M 0.01% 1129

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Jump Financial's KYTX Position: Q1 2026 in Review

Jump Financial reduced its Kyverna Therapeutics (KYTX) stake by 34% in Q1 2026, selling an estimated $229K and leaving 52,762 shares worth $455K. The position accounts for 0.01% of the portfolio, ranked #1298.

Jump Financial first reported a position in KYTX in Q2 2024 and has held it in 3 quarters since. The position peaked at $755K in Q4 2025. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • Jump Financial held 52,762 shares of Kyverna Therapeutics worth $455K as of Q1 2026.
  • Jump Financial sold 27,537 Kyverna Therapeutics shares in Q1 2026, an estimated $229K.
  • Kyverna Therapeutics made up 0.01% of Jump Financial's portfolio in Q1 2026, its #1298 holding.
  • Jump Financial first reported a position in Kyverna Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • Jump Financial's Kyverna Therapeutics position peaked at $755K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.